课题基金 / 基金详情

Pilot Study: POPULATION PHARMACOLOGY

Pilot Study: POPULATION PHARMACOLOGY
试点研究:群体药理学
批准号:
8126776
负责人:
ROBERT M PLENGE
金额:
$31.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2017-05-31

项目摘要

项目成果

ROBERT M PLENGE的其他基金

相似基金

相关文献

中文摘要
翻译
我们的试点项目最具创新性的方面是使用电子病历数据来定义非甾体抗炎药的使用和心血管疾病
英文摘要
The most innovative aspect of our Pilot Project is to use EMR data to define NSAID usage and CVD outcomes. We will use EMR data to define a large cohort of RA and OA patients. We will create an ondemand registry to target biospecimen collection using discarded tissue from routine care. We have already demonstrated that such an approach is feasible for patients with RA (see Preliminary Data in the Approach Section). We have not yet demonstrated that we can define NSAID usage and CVD outcome with high sensitivity and specificity. If we are indeed able to define precisely NSAID usage and CVD outcome, then we will be in a position to conduct large, well-powered genomic studies later in the funding period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deep Re-Sequencing of Rheumatoid Arthritis Risk Loci
  • 批准号:
    7943500
  • 项目类别:
  • 资助金额:
    $25.05万
  • 财政年份:
    2010
  • 负责人:
    ROBERT M PLENGE
  • 依托单位:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
  • 批准号:
    8293200
  • 项目类别:
  • 资助金额:
    $159.6万
  • 财政年份:
    2010
  • 负责人:
    ROBERT M PLENGE
  • 依托单位:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
  • 批准号:
    8321217
  • 项目类别:
  • 资助金额:
    $18.75万
  • 财政年份:
    2010
  • 负责人:
    ROBERT M PLENGE
  • 依托单位:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
  • 批准号:
    7868547
  • 项目类别:
  • 资助金额:
    $150.0万
  • 财政年份:
    2010
  • 负责人:
    ROBERT M PLENGE
  • 依托单位:
海外基金